相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats
Erik J. Henriksen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice
R. Rao et al.
DIABETOLOGIA (2007)
Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes
Erik J. Henriksen et al.
CURRENT DRUG TARGETS (2006)
Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats
Betsy B. Dokken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: Molecular characterization in liver and muscle
O Kaidanovich-Beilin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle
BB Dokken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling
Z Liberman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interactions of exercise training and α-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats
V Saengsirisuwan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes
AS Wagman et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Effects of specific conjugated linoleic acid isomers on growth characteristics in obese Zucker rats
SR Sanders et al.
LIPIDS (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3
B Plotkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo
DB Ring et al.
DIABETES (2003)
Voltage-sensitive dye mapping in Langendorff-perfused rat hearts
A Nygren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (falfa) rats
GW Cline et al.
DIABETES (2002)
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle
SE Nikoulina et al.
DIABETES (2002)
The effects of high-fat diet on exercise-induced changes in metabolic parameters in Zucker fa/fa rats
MT Kibenge et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
SE Nikoulina et al.
DIABETES (2000)
分享论文
